Cargando…
Personalized Immunomodulatory Therapy for Atopic Dermatitis: An Allergist's View
The current standard medical therapy for atopic dermatitis (AD) mainly focuses on symptomatic relief by controlling skin inflammation with topical corticosteroids and/or topical calcineurin inhibitors. However, the clinical efficacy of pharmacological therapy is often disappointing to both patients...
Autor principal: | Nahm, Dong-Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Dermatological Association; The Korean Society for Investigative Dermatology
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4530142/ https://www.ncbi.nlm.nih.gov/pubmed/26273148 http://dx.doi.org/10.5021/ad.2015.27.4.355 |
Ejemplares similares
-
Different Approaches to Atopic Dermatitis by Allergists, Dermatologists, and Pediatricians
por: Zuccolo de Bortoli, Suzieni Padoin, et al.
Publicado: (2021) -
Current Management of Moderate-to-Severe Atopic Dermatitis: A Survey of Allergists, Pediatric Allergists and Dermatologists in Korea
por: Yum, Hye Yung, et al.
Publicado: (2018) -
Regulatory T Cell-Targeted Immunomodulatory Therapy for Long-Term Clinical Improvement of Atopic Dermatitis: Hypotheses and Perspectives
por: Nahm, Dong-Ho
Publicado: (2023) -
Immunomodulatory Role of Staphylococcus aureus in Atopic Dermatitis
por: Chung, Ethan Jachen, et al.
Publicado: (2022) -
Associations of Atopic Dermatitis With Obesity and Unmarried Status in Young Adults: Evidence for Atopic Dermatitis as a Life-Style Disorder With High Social Impact
por: Nahm, Dong-Ho
Publicado: (2016)